⌘K

Login Start Free

KEMPHARM, INC·4

Mar 5, 4:18 PM ET

Mickle Travis C 4

4 · KEMPHARM, INC · Filed Mar 5, 2020

Insider Transaction Report

Form 4

Period: 2020-03-05

KEMPHARM, INCKMPH

Mickle Travis C

DirectorPresident & CEO10% Owner

Transactions

Purchase
Common Stock
2020-03-05$0.33/sh+3,000$1,002→ 1,759,117 total
Purchase
Common Stock
2020-03-05$0.33/sh+4,500$1,499→ 1,763,617 total
Purchase
Common Stock
2020-03-05$0.33/sh+4,500$1,502→ 1,768,117 total
Purchase
Common Stock
2020-03-05$0.33/sh+3,000$990→ 1,771,117 total
Purchase
Common Stock
2020-03-05$0.33/sh+2,500$825→ 1,778,117 total
Purchase
Common Stock
2020-03-05$0.33/sh+3,000$1,003→ 1,756,117 total
Purchase
Common Stock
2020-03-05$0.33/sh+4,500$1,484→ 1,775,617 total

Holdings

Common Stock
(indirect: By Trust)
157,197
Common Stock
(indirect: By Trust)
123,217
Common Stock
100,604
Common Stock
(indirect: By Trust)
243,880
Common Stock
(indirect: By Trust)
21,466
Common Stock
(indirect: By LLC)
16,550

Footnotes (2)

[F1]Held jointly with Christal M.M. Mickle.
[F2]The Reporting Person and Christal M.M. Mickle are the managing members of Mickle Investments, LLC.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4